Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siegfried Janz

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Journal of the National Cancer Institute. Monographs|July 24, 2008
t(14;18) Translocations and risk of follicular lymphomaCharles S Rabkin, Carsten Hirt, Siegfried Janz, et al.
Genes, Chromosomes & Cancer|March 8, 2005
Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocationNicole McNeil, Joong Su Kim, Thomas Ried, et al.
British Journal of Haematology|July 7, 2007
Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individualsCarsten Hirt, Gottfried Dölken, Siegfried Janz, et al.
Optics Letters|August 12, 2005
Wavelength-dispersive device based on a Fourier-transform Michelson-type arrayed waveguide gratingPavel Cheben, Ian Powell, Siegfried Janz, et al.
Optics Express|December 19, 2025
Planar waveguide circulating Gaussian beam resonators on a silicon photonic chipSiegfried Janz, Shurui Wang, Rubin Ma, et al.
Journal of Translational Medicine|July 8, 2024
Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myelomaVivian Zhou, Manya Yu, Jiaqi Fu, et al.
Genes, Chromosomes & Cancer|July 20, 2007
In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell developmentYi Yan, Sung Sup Park, Siegfried Janz, et al.
Blood Advances|July 17, 2025
Molecular and Immunological Determinants of Long-Term Survival in Multiple MyelomaKhanmi Kasomva, Kritika Yadav, Siegfried Janz, et al.
Experimental Cell Research|October 6, 2024
Changes in the immune microenvironment during plasma cell tumor development in the IL6Myc mouse model of human multiple myelomaManya Yu, Vivian Zhou, Michael D Pisano, et al.
Oncotarget|September 29, 2015
Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?Reinaldo Franqui-Machin, Erik B Wendlandt, Siegfried Janz, et al.
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute. Monographs|July 24, 2008
t(14;18) Translocations and risk of follicular lymphomaCharles S Rabkin, Carsten Hirt, Siegfried Janz, et al.
Genes, Chromosomes & Cancer|March 8, 2005
Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocationNicole McNeil, Joong Su Kim, Thomas Ried, et al.
British Journal of Haematology|July 7, 2007
Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individualsCarsten Hirt, Gottfried Dölken, Siegfried Janz, et al.
Optics Letters|August 12, 2005
Wavelength-dispersive device based on a Fourier-transform Michelson-type arrayed waveguide gratingPavel Cheben, Ian Powell, Siegfried Janz, et al.
Optics Express|December 19, 2025
Planar waveguide circulating Gaussian beam resonators on a silicon photonic chipSiegfried Janz, Shurui Wang, Rubin Ma, et al.
Journal of Translational Medicine|July 8, 2024
Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myelomaVivian Zhou, Manya Yu, Jiaqi Fu, et al.
Genes, Chromosomes & Cancer|July 20, 2007
In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell developmentYi Yan, Sung Sup Park, Siegfried Janz, et al.
Blood Advances|July 17, 2025
Molecular and Immunological Determinants of Long-Term Survival in Multiple MyelomaKhanmi Kasomva, Kritika Yadav, Siegfried Janz, et al.
Experimental Cell Research|October 6, 2024
Changes in the immune microenvironment during plasma cell tumor development in the IL6Myc mouse model of human multiple myelomaManya Yu, Vivian Zhou, Michael D Pisano, et al.
Oncotarget|September 29, 2015
Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?Reinaldo Franqui-Machin, Erik B Wendlandt, Siegfried Janz, et al.
Pageof 16